Several studies have shown KLF4 is critical mediator of obesity‐related complications, including cardiomyopathy, systemic inflammation and metabolic syndromes.13, 24 Therefore, present study further explored the effects of renal KLF4 in obesity‐related nephropathy. This evidence concerns the gene KLF4 and kidney disorder.